News
Latest
News
NEREUS meets Phase III endpoints for GLP-1-related vomiting
Vanda Pharmaceuticals has reported positive Phase III results for NEREUS (tradipitant), an NK-1 receptor antagonist, for the prevention of semaglutide-associated vomiting. The company plans to discuss the findings with the FDA ahead of a potential regulatory submission.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
NewsFDA approves novel self-administered autoinjector for generalised myasthenia gravis
US approval of UCB’s Zilbrysq provides a second self-administration option for AChR antibody-positive patients with the rare disease.
NewsMerck KGaA strengthens rare disease pipeline with $1.3bn Silence acquisition
Investment involves potential best-in-class therapy from siRNA specialist Silence Therapeutics.
NewsSanofi begins construction on next-generation insulin facility in Frankfurt
New manufacturing plant set to strengthen supply security for insulin in Europe.
NewsCHMP recommends first broad RAS-targeted therapy for metastatic pancreatic cancer
The EMA’s human medicines committee’s positive opinion is based on data showing the oral therapy reduced the risk of death by more than fifty percent compared to chemotherapy.
More news
News
FDA seeks feedback on new framework for rare disease drug development
The US agency proposes its new regulatory framework will holistically address the unique challenges of rare disease drug development.
News
Roche licenses novel RNAi therapy from Rona in $1bn obesity deal
Agreement targets RNAi therapy with a unique mechanism that distinguishes itself in the increasingly crowded incretin therapy landscape for obesity and metabolic disease.
News
European Pharmacopoeia launches working party for 3D-printed medicines
The new group will develop pharmacopoeial quality standards for 3D-printed medicinal products, reflecting the technology’s growing role in personalised medicine manufacturing.
News
RayzeBio’s alpha-based radiopharma therapy strikes hot in first Phase III readout
Topline results for the alpha-isotope based targeted radiopharmaceutical therapy highlight significant improvement in progression-free survival in SSTR-positive GEP-NETs.
News
FDA approves Roche’s Tecentriq immunotherapy combination for dMMR colon cancer
Authorisation positions monoclonal antibody as a new post-surgery standard of care in stage III deficient mismatch repair colon cancer.
News
CPHI selects 2026 Pharma Awards winners
Honourees span API development, finished formulation, supply chain, sustainable innovation and leadership excellence.
News
Nobel Prize awarded for optogenetics
The 2026 Nobel Prize in Physiology or Medicine award celebrates a key advancement in neuroscience following breakthrough findings from a 2005 research paper.
News
Bayer invests $2.2bn in new Ohio manufacturing facility
Automated, modular manufacturing site to support growth of firm’s oncology, cardiovascular and renal care portfolio.
News
Teva and Samsung Bioepis expand biosimilar collaboration
Partnership expansion will help strengthen Samsung Bioepis and Teva Pharmaceutical’s global market position and respective pipelines.
News
Exposure rate influences microbial viability risk during pharmaceutical freeze-thaw cycling
Research supports pharmaceutical microbiological risk assessments and thaw-handling steps during manufacture and storage.
News
AstraZeneca commits $2bn to advance ADC combination medicines for cancer
Investment and collaboration agreement with Summit Therapeutics to accelerate next-generation immuno-oncology regimens across multiple tumour types.
News
IMS Solutions launches ‘steroid fingerprint’ diagnostic technology
A new Imperial College London and University of Birmingham spinout is developing mass spectrometry-based tests to improve the diagnosis and stratification of conditions linked to disordered steroid metabolism.